ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

STATE STREET CORP's Holding History (CIK: 0000093751)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 21,920,000 Value ($000) $32,333 Avg Close — Range —
Q3 2025
Shares 21,170,000 Value ($000) $34,878 Avg Close — Range —
Q2 2025
Shares 19,920,000 Value ($000) $25,946 Avg Close — Range —
Q1 2025
Shares 21,445,000 Value ($000) $24,727 Avg Close — Range —
Q4 2024
Shares 23,158,000 Value ($000) $24,745 Avg Close — Range —
Q3 2024
Shares 21,758,000 Value ($000) $25,482 Avg Close — Range —
Q2 2024
Shares 22,108,000 Value ($000) $23,913 Avg Close — Range —
Q1 2024
Shares 21,858,000 Value ($000) $20,529 Avg Close — Range —
Q4 2023
Shares 22,958,000 Value ($000) $22,783 Avg Close — Range —
Q3 2023
Shares 23,158,000 Value ($000) $21,508 Avg Close — Range —